Literature DB >> 9626397

Bone morphogenetic proteins: from basic studies to clinical approaches.

T Sakou1.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9626397     DOI: 10.1016/s8756-3282(98)00053-2

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


× No keyword cloud information.
  56 in total

1.  Sequential actions of BMP receptors control neural precursor cell production and fate.

Authors:  D M Panchision; J M Pickel; L Studer; S H Lee; P A Turner; T G Hazel; R D McKay
Journal:  Genes Dev       Date:  2001-08-15       Impact factor: 11.361

Review 2.  New insights into the pathogenesis and treatment of primary pulmonary hypertension.

Authors:  N Rudarakanchana; R C Trembath; N W Morrell
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

Review 3.  HMG CoA reductase inhibitors and the skeleton: a comprehensive review.

Authors:  D C Bauer
Journal:  Osteoporos Int       Date:  2003-05-08       Impact factor: 4.507

Review 4.  Surface treatments and roughness properties of Ti-based biomaterials.

Authors:  Andrea Bagno; Carlo Di Bello
Journal:  J Mater Sci Mater Med       Date:  2004-09       Impact factor: 3.896

Review 5.  [Bone morphogenetic proteins in the skeletal system].

Authors:  C P Bramlage; T Häupl; C Kaps; P Bramlage; G-A Müller; F Strutz
Journal:  Z Rheumatol       Date:  2005-09       Impact factor: 1.372

Review 6.  Prostaglandin E(2) receptors in bone formation.

Authors:  M Li; D D Thompson; V M Paralkar
Journal:  Int Orthop       Date:  2007-06-26       Impact factor: 3.075

Review 7.  Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence.

Authors:  P V Giannoudis; N K Kanakaris; T A Einhorn
Journal:  Osteoporos Int       Date:  2007-08-12       Impact factor: 4.507

8.  Bone morphogenetic protein-2 is a negative regulator of hepatocyte proliferation downregulated in the regenerating liver.

Authors:  Cui-Ping Xu; Wen-Min Ji; Gijs R van den Brink; Maikel P Peppelenbosch
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

9.  Phosphatidylethanolamine biomimetic coating increases mesenchymal stem cell osteoblastogenesis.

Authors:  Bérengère J C Luthringer; Uma M R Katha; Regine Willumeit
Journal:  J Mater Sci Mater Med       Date:  2014-07-01       Impact factor: 3.896

10.  Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures.

Authors:  Neil Ghodadra; Kern Singh
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.